Chai Discovery
✓ Verified
Healthcare AI
AI drug discovery / antibody design
Series C
Chai Discovery is an AI biotechnology company that builds generative and predictive models for de novo antibody design and pre-clinical drug discovery, aiming to help pharmaceutical teams design biomolecules with defined functional properties rather than relying on trial-and-error discovery.
Company Details
- Website
- chaidiscovery.com
- Headquarters
- San Francisco, California, United States
- Founded
- 2024
- Funding
- $600M+
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring